4.3 Review

Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel

Publisher

ELSEVIER
DOI: 10.1016/j.ejogrb.2011.04.025

Keywords

Acute menorrhagia; Bleeding disorder; Hemostasis management; Consensus; Coagulation factor

Funding

  1. CSL Behring
  2. Duramed Pharmaceuticals
  3. Ferring
  4. Wyeth
  5. Bayer
  6. Novo Nordisk
  7. CSL Behring (Marburg, Germany)

Ask authors/readers for more resources

Acute menorrhagia is a common gynecological disorder. Prevalence is high among women with inherited bleeding disorders and recent guidance for optimal management is lacking. Following a comprehensive review of the literature, an international expert panel in obstetrics, gynecology and hematology reached consensus on recommendations regarding the management of acute menorrhagia in women without a diagnosed bleeding disorder, as well as in patients with von Willebrand disease, platelet function disorders and other rare hemostatic disorders. The causes and predictors of acute menorrhagia are discussed and special consideration is given for the treatment of women on anticoagulation therapy. This review and accompanying recommendations will provide guidance for healthcare practitioners in the emergency management of acute menorrhagia. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available